Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

ClinicalTrials.gov ID: NCT00598273

Public ClinicalTrials.gov record NCT00598273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 25, 2026, 6:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AFX01-11: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Correction of Anemia in Patients With Chronic Renal Failure (CRF) Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment

Study identification

NCT ID: NCT00598273
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Affymax; Industry
Enrollment: 490 participants

Conditions and interventions

Conditions

Interventions

peginesatide Drug
Darbepoetin alfa Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2007
Primary completion: Feb 28, 2009
Completion: Jan 31, 2010
Last update posted: Feb 11, 2013

2007 – 2010

United States locations

U.S. sites: 68
U.S. states: 30
U.S. cities: 65

Facility	City	State	ZIP	Site status
Research Facility	Montgomery	Alabama	36106	—
Research Facility	Tempe	Arizona	85306	—
Research Facility	Hot Springs	Arkansas	71901	—
Research Facility	Bakersfield	California	93309	—
Research Facility	Chula Vista	California	91910	—
Research Facility	Glendale	California	91204	—
Research Facility	Huntington Beach	California	92646	—
Research Facility	Los Angeles	California	90095	—
Research Facility	Orange	California	92868	—
Research Facility	Paramount	California	90723	—
Research Facility	Pasadena	California	91106	—
Research Facility	Riverside	California	92505	—
Research Facility	San Dimas	California	91773	—
Research Facility	Stanford	California	94305-6203	—
Research Facility	Whittier	California	90603	—
Research Facility	Whittier	California	90606	—
Research Facility	Yuba City	California	95991	—
Research Facility	Thornton	Colorado	80031	—
Research Facility	Washington D.C.	District of Columbia	20037	—
Research Facility	Holly Hill	Florida	32117	—
Research Facility	Hudson	Florida	34667	—
Research Facility	Miami	Florida	33173	—
Research Facility	Ocala	Florida	34471	—
Research Facility	Orlando	Florida	32804	—
Research Facility	Tampa	Florida	33614	—
Research Facility	Augusta	Georgia	30901	—
Research Facility	Honolulu	Hawaii	96817	—
Research Facility	Chicago	Illinois	60616	—
Research Facility	Evergreen Park	Illinois	60805	—
Research Facility	Hines	Illinois	60141	—
Research Facility	Evansville	Indiana	47714	—
Research Facility	Lafayette	Indiana	47904	—
Research Facility	Wichita	Kansas	67214	—
Research Facility	Shreveport	Louisiana	71101	—
Research Facility	Bethesda	Maryland	20814	—
Research Facility	Fall River	Massachusetts	02720	—
Research Facility	Worcester	Massachusetts	01608	—
Research Facility	Midland	Michigan	48640	—
Research Facility	Columbus	Mississippi	39705	—
Research Facility	Kansas City	Missouri	64128	—
Research Facility	Northfield	New Jersey	08225	—
Research Facility	Toms River	New Jersey	08755	—
Research Facility	Binghamton	New York	13903	—
Research Facility	Great Neck	New York	11021	—
Research Facility	Mineola	New York	11501	—
Research Facility	Charlotte	North Carolina	28208	—
Research Facility	Oklahoma City	Oklahoma	73116	—
Research Facility	Bend	Oregon	97701	—
Research Facility	Portland	Oregon	97210	—
Research Facility	Allentown	Pennsylvania	18103	—
Research Facility	Erie	Pennsylvania	16507	—
Research Facility	Johnstown	Pennsylvania	15905	—
Research Facility	Providence	Rhode Island	02904	—
Research Facility	Orangeburg	South Carolina	29118	—
Research Facility	Rock Hill	South Carolina	29732	—
Research Facility	Clarksville	Tennessee	37043	—
Research Facility	Knoxville	Tennessee	37923	—
Research Facility	Nashville	Tennessee	37205	—
Research Facility	Austin	Texas	78705	—
Research Facility	Corpus Christi	Texas	78404	—
Research Facility	Corsicana	Texas	75110	—
Research Facility	Edinburg	Texas	78539	—
Research Facility	Houston	Texas	77030	—
Research Facility	Houston	Texas	77099	—
Research Facility	San Antonio	Texas	78215	—
Research Facility	San Antonio	Texas	78229	—
Research Facility	Salem	Virginia	24153	—
Research Facility	Bluefield	West Virginia	24701	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00598273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 11, 2013 · Synced Jun 25, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00598273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →